Ullrich Graeven
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Hematology top 1%
Papers in
- Oncology 93
- Colorectal Cancer Treatments and Studies 65
- Cancer Treatment and Pharmacology 26
- Colorectal Cancer Surgical Treatments 12
-
- Genetic factors in colorectal cancer 28
- Co-authors
- Wolff SchmiegelSüleyman ErgünM StockschläderDieter K. HossfeldWalter FiedlerNerbil KilicHans‐Joachim SchmollRainer Porschen
- Journals
- Journal of Clinical Oncology (25 papers)Annals of Oncology (16 papers)Blood (10 papers)European Journal of Cancer (9 papers)International Journal of Cancer (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Ullrich Graeven
126 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 121
- Oncology 2.9k
- Hematology 644
- Hepatology 397
- Pathology and Forensic Medicine 747
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Ullrich Graeven
This map shows the geographic impact of Ullrich Graeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ullrich Graeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ullrich Graeven more than expected).
Fields of papers citing papers by Ullrich Graeven
This network shows the impact of papers produced by Ullrich Graeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ullrich Graeven. The network helps show where Ullrich Graeven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ullrich Graeven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 13 | |
| 12 | 2020 | 6 | |
| 13 | 2017 | 62 | |
| 14 | 2016 | 18 | |
| 15 | 2011 | 12 | |
| 16 | 2008 | 16 | |
| 17 | 2004 | 13 | |
| 18 | Kolorektales Karzinom : Prävention und Früherkennung in der asymptomatischen Bevölkerung : Vorsorge bei Risikopatienten : Endoskopische Diagnostik, Therapie und Nachsorge von Polypen und Karzinomen | 2000 | 18 |
| 19 | 2000 | 26 | |
| 20 | 1997 | 7 |
About Ullrich Graeven
Ullrich Graeven is a scholar working on Oncology, Pathology and Forensic Medicine, Hematology, Hepatology and Pulmonary and Respiratory Medicine, having authored 135 papers that have together received 4.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (65 papers), Gastric Cancer Management and Outcomes (28 papers), Genetic factors in colorectal cancer (28 papers), Cancer Treatment and Pharmacology (26 papers), Lung Cancer Treatments and Mutations (16 papers), Colorectal and Anal Carcinomas (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Colorectal Cancer Surgical Treatments (12 papers). The work is most often cited by research in Oncology (2.9k citations), Hematology (644 citations), Hepatology (397 citations), Pathology and Forensic Medicine (747 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Ullrich Graeven has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Wolff Schmiegel, Süleyman Ergün, M Stockschläder, Dieter K. Hossfeld, Walter Fiedler, Nerbil Kilic, Hans‐Joachim Schmoll, Rainer Porschen, Dirk Arnold and Andrea Tannapfel. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, European Journal of Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.